Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Assets (2016 - 2025)

Historic Assets for Assembly Biosciences (ASMB) over the last 11 years, with Q3 2025 value amounting to $240.0 million.

  • Assembly Biosciences' Assets rose 13936.99% to $240.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $240.0 million, marking a year-over-year increase of 13936.99%. This contributed to the annual value of $119.2 million for FY2024, which is 1290.35% down from last year.
  • According to the latest figures from Q3 2025, Assembly Biosciences' Assets is $240.0 million, which was up 13936.99% from $80.8 million recorded in Q2 2025.
  • Over the past 5 years, Assembly Biosciences' Assets peaked at $278.9 million during Q1 2021, and registered a low of $51.6 million during Q3 2023.
  • Over the past 5 years, Assembly Biosciences' median Assets value was $119.9 million (recorded in 2024), while the average stood at $143.3 million.
  • Its Assets has fluctuated over the past 5 years, first plummeted by 5751.26% in 2023, then surged by 13936.99% in 2025.
  • Quarter analysis of 5 years shows Assembly Biosciences' Assets stood at $191.1 million in 2021, then plummeted by 46.72% to $101.8 million in 2022, then surged by 34.41% to $136.8 million in 2023, then dropped by 12.9% to $119.2 million in 2024, then skyrocketed by 101.39% to $240.0 million in 2025.
  • Its Assets stands at $240.0 million for Q3 2025, versus $80.8 million for Q2 2025 and $99.0 million for Q1 2025.